A Phase I Study Investigating Safety Immunological Effects of Peripheral Blood T Lymphocytes Transduced With Anti LewisY Chimeric Receptor Gene in LewisY Positive Myeloma, Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anti-Lewis-Y transduced T cells (Primary)
- Indications Acute myeloid leukaemia; Multiple myeloma; Myelodysplastic syndromes
- Focus Adverse reactions; Pharmacogenomic
- 04 Dec 2012 Biomarkers information updated
- 04 Dec 2012 New trial record